Jennifer J Kordich

age ~54

from Ada, MI

Also known as:
  • Jennifer J Reep
Phone and address:
158 Donnybrook Ct NE, Ada, MI 49301

Jennifer Kordich Phones & Addresses

  • 158 Donnybrook Ct NE, Ada, MI 49301
  • Issaquah, WA
  • Grand Rapids, MI
  • Aurora, OH
  • 3015 255Th Ave, Sammamish, WA 98075
  • Duvall, WA
  • Cincinnati, OH

Us Patents

  • Enhanced Death Receptor Agonists

    view source
  • US Patent:
    20130064838, Mar 14, 2013
  • Filed:
    May 13, 2011
  • Appl. No.:
    13/698040
  • Inventors:
    Jonathan David Graves - Belmont MA, US
    Jennifer Joy Kordich - Sammamish WA, US
    Susan Ellen Cottrell - Seattle WA, US
    Chang-Pin Huang - Shoreline WA, US
  • Assignee:
    AMGEN INC. - Thousand Oaks CA
  • International Classification:
    C07K 16/28
    A61P 35/00
    C12N 5/09
    C12Q 1/68
    A61K 39/395
  • US Classification:
    4241741, 435 611, 5303891, 5303873, 435366
  • Abstract:
    Methods and compositions for treatment of cancer in a human patient comprising administering a therapeutically effective amount of an Fc-polypeptide agonist of DR5 having high-affinity to FCGR3A. Methods of making the Fc-polypeptides are provided.
  • Fusion Proteins In Cancer

    view source
  • US Patent:
    20130095111, Apr 18, 2013
  • Filed:
    Jun 28, 2011
  • Appl. No.:
    13/805321
  • Inventors:
    Kim Coign Quon - Seattle WA, US
    Gene Cutler - San Francisco CA, US
    Jennifer Joy Kordich - Sammamish WA, US
  • Assignee:
    AMGEN INC. - Thousand Oaks CA
  • International Classification:
    A61K 47/48
    G01N 33/68
    C07K 16/30
  • US Classification:
    4241391, 5303879, 5303917, 5303873, 4241781, 435 723, 435 611, 435 614, 435375
  • Abstract:
    The present invention provides fusion proteins expressed by cancer cells, antibodies and other antigen-binding agents that specifically bind to the fusion proteins, and compositions and methods for using the antibodies and other antigen-binding agents to detect, characterize, and treat cancer.
  • Dr5 Receptor Agonist Combinations

    view source
  • US Patent:
    20190284290, Sep 19, 2019
  • Filed:
    Oct 31, 2018
  • Appl. No.:
    16/176343
  • Inventors:
    - Thousand Oaks CA, US
    Jonathan David Graves - Belmont MA, US
    Jennifer Joy Kordich - Ada MI, US
    Julia Catherine Piasecki - Seattle WA, US
    Ian Nevin Foltz - Burnaby, CA
  • International Classification:
    C07K 16/28
    A61K 39/395
    A61K 38/19
  • Abstract:
    The present invention includes apoptotic compositions and methods for inducing apoptosis of cancer cells independent of NK cells. An apoptotic composition comprises a cooperative combination of antibodies that specifically bind to human DR5, or a cooperative combination of an anti-DR5 antibody and TRAIL. Administration of therapeutically effective amounts of an apoptotic composition induces apoptosis of apoptosis sensitive cancer cells.
  • Dr5 Receptor Agonist Combinations

    view source
  • US Patent:
    20150056204, Feb 26, 2015
  • Filed:
    Mar 27, 2013
  • Appl. No.:
    14/388762
  • Inventors:
    - Thousand Oaks CA, US
    Jonathan David Graves - Belmont MA, US
    Jennifer Joy Kordich - Ada MI, US
    Julia Catherine Piasecki - Seattle WA, US
    Ian Nevin Foltz - Burnaby, CA
  • International Classification:
    C07K 16/28
    A61K 38/19
    A61K 39/395
  • US Classification:
    4241361, 4241581
  • Abstract:
    The present invention includes apoptotic compositions and methods for inducing apoptosis of cancer cells independent of NK cells. An apoptotic composition comprises a cooperative combination of antibodies that specifically bind to human DR5, or a cooperative combination of an anti-DR5 antibody and TRAIL. Administration of therapeutically effective amounts of an apoptotic composition induces apoptosis of apoptosis sensitive cancer cells.

Get Report for Jennifer J Kordich from Ada, MI, age ~54
Control profile